StemCells, Inc. to Participate at the 17th Annual BIO CEO & Investor Conference
02 févr. 2015 08h00 HE
|
StemCells, Inc.
NEWARK, Calif., Feb. 2, 2015 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that Management will make a presentation on the Company's programs and operations at the 17th Annual BIO...
Stem Cells Inc. Posts Letter to Shareholders
26 janv. 2015 08h00 HE
|
StemCells, Inc.
NEWARK, Calif., Jan. 26, 2015 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing novel cell-based therapeutics for disorders of the central nervous system,...
StemCells, Inc. Transplants First Participant in Phase II Clinical Trial in Cervical Spinal Cord Injury
18 déc. 2014 08h00 HE
|
StemCells, Inc.
NEWARK, Calif., Dec. 18, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a world leader in the research and development of cell-based therapeutics for the treatment of disorders of the central...
StemCells, Inc. Hosts Leading Biotech Investors and Analysts at Inaugural Event
02 déc. 2014 08h00 HE
|
StemCells, Inc.
NEWARK, Calif., Dec. 2, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leader in the development of cell-based therapies for disorders of the central nervous system (CNS), hosted its first...
StemCells, Inc. to Host Inaugural Investor and Analyst Event in New York
20 nov. 2014 08h00 HE
|
StemCells, Inc.
NEWARK, Calif., Nov. 20, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), who pioneered the discovery and development of HuCNS-SC® cells, a proprietary population of highly purified,...
StemCells, Inc. Reports Third Quarter 2014 Financial and Operating Results
05 nov. 2014 08h00 HE
|
StemCells, Inc.
NEWARK, Calif., Nov. 5, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), which pioneered the discovery and development of HuCNS-SC® cells, a proprietary population of highly purified,...
StemCells, Inc. to Host Inaugural Investor and Analyst Event in New York
03 nov. 2014 17h25 HE
|
StemCells, Inc.
NEWARK, Calif., Nov. 3, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), who pioneered the discovery and development of HuCNS-SC® cells, a proprietary population of highly purified,...
StemCells, Inc. Initiates Phase II Clinical Trial in Cervical Spinal Cord Injury
07 oct. 2014 08h00 HE
|
StemCells, Inc.
NEWARK, Calif., Oct. 7, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a world leader in the research and development of cell based therapies for the treatment of disorders of the central...
StemCells, Inc. to Participate at the 2014 Stem Cell Meeting on the Mesa
01 oct. 2014 08h00 HE
|
StemCells, Inc.
NEWARK, Calif., Oct. 1, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that President and CEO Martin McGlynn will make a presentation on the Company's programs and operations...
StemCells, Inc. to Participate at the 16th Annual Rodman & Renshaw Global Investment Conference
04 sept. 2014 16h05 HE
|
StemCells, Inc.
NEWARK, Calif., Sept. 4, 2014 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that management will present at the 16th Annual Rodman & Renshaw Global Investment Conference...